Publication: Inhaled budesonide aerosols in treatment of childhood asthma
Issued Date
1988-12-01
Resource Type
ISSN
0125877X
Other identifier(s)
2-s2.0-0024209673
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.6, No.2 (1988), 111-115
Suggested Citation
P. Phanichyakarn, E. C.K. Wong Inhaled budesonide aerosols in treatment of childhood asthma. Asian Pacific Journal of Allergy and Immunology. Vol.6, No.2 (1988), 111-115. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/15553
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Inhaled budesonide aerosols in treatment of childhood asthma
Author(s)
Other Contributor(s)
Abstract
Twenty-six children with chronic bronchial asthma, 19 boys and 7 girls, aged between 6 and 16 years with duration of asthma ranging from 1-12 years, were studied by a control, oral prednisolone 5 mg twice a day and inhaled budesonide 200 μg twice daily, each for 3 weeks. The clinical efficacy assessed daily by day and night symptom scores of cough, wheeze, sleep disturbance, limitation of activity, symptomatic inhaled terbutaline usage, daily morning and afternoon Peak Expiratory Flow Rate (PEFR), and weekly PEFR and Forced Expiratory Volume in 1 second (FEV 1 ) in percent of predict, showed statistically significant improvement during the inhaled budesonide aerosol and oral prednisolone treatment periods in comparison with the control. No side effect was observed during any study periods.